How can European Life Sciences Compete for More Capital?

McDermott Will & Emery and Paris Healthcare Drinks was pleased to invite you to a round table and networking event discussing the difficulty life sciences companies can face in competing for capital and how to overcome those challenges.

The science is there, as are top researchers and outstanding companies offering disruptive technologies and products. Supportive public polices provide numerous subsidies and favorable legal frameworks… yet Europe is still lagging far behind the United States and China in terms of raising capital and attracting investors.

Can the situation change? What will trigger change for better and more accessible funding for European life sciences companies? Join us for an in depth discussion and the opportunity for interactive debate with our key speakers:

Marietta Wu – Managing Partner, Quan Capital
Thierry Laugel – Managing Partner, Kurma Partners
Emmanuelle Trombe – Head of the Paris Life Sciences Team, McDermott Will & Emery
For any queries, please contact Barbara Bebiano.